MedTrace Logo

Evaluation of ReDS Pro System V2.7 and ReDS ICU in Patients With Heart Failure

NCT05405504 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-06-14

No results posted yet for this study

Summary

The study is an investigator-initiated, prospective cohort trial. The trial aims to evaluate ReDS Pro System V2.7 and ReDS ICU in patients with heart failure (HF).

Conditions

Interventions

DEVICE

Remote Dielectric Sensing (ReDS)

Non-invasive device designed for the measurement of lung fluid using extremely low power electromagnetic waves. The ReDS Pro System V2.7 system has CE approval (3900874CE01) and FDA clearance.

Sponsors & Collaborators

  • Christian Hassager

    lead OTHER

Principal Investigators

  • Christian Hassager, MD, DMSc, Professor · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2024-02-01
Completion
2024-02-01
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05405504 on ClinicalTrials.gov